AKLI Akili Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AKLI

Price (delayed)

$0.25

Market cap

$19.63M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.76

Enterprise value

-$40.34M

Highlights
AKLI's gross profit has soared by 147% QoQ
The revenue has soared by 61% from the previous quarter
AKLI's EPS is up by 31% from the previous quarter but it is down by 19% YoY
Akili's equity has decreased by 47% YoY and by 15% QoQ
Akili's quick ratio has decreased by 42% YoY and by 12% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Peers: OBIO OM

Key stats

What are the main financial stats of AKLI
Market
Shares outstanding
78.51M
Market cap
$19.63M
Enterprise value
-$40.34M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.33
Price to sales (P/S)
11.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-24.04
Earnings
Revenue
$1.68M
EBIT
-$57.08M
EBITDA
-$56.09M
Free cash flow
-$58.01M
Per share
EPS
-$0.76
Free cash flow per share
-$0.74
Book value per share
$0.75
Revenue per share
$0.02
TBVPS
$1.03
Balance sheet
Total assets
$80.38M
Total liabilities
$21.85M
Debt
$15.49M
Equity
$58.53M
Working capital
$65.06M
Liquidity
Debt to equity
0.26
Current ratio
6.02
Quick ratio
5.84
Net debt/EBITDA
1.07
Margins
EBITDA margin
-3,342.6%
Gross margin
51.2%
Net margin
-3,545.5%
Operating margin
-3,843%
Efficiency
Return on assets
-58.1%
Return on equity
-78.5%
Return on invested capital
-166.8%
Return on capital employed
-84.7%
Return on sales
-3,401.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AKLI stock price

How has the Akili stock price performed over time
Intraday
4.17%
1 week
4.17%
1 month
-34.38%
1 year
-76.19%
YTD
-48.68%
QTD
-13.67%

Financial performance

How have Akili's revenue and profit performed over time
Revenue
$1.68M
Gross profit
$859,000
Operating income
-$64.49M
Net income
-$59.49M
Gross margin
51.2%
Net margin
-3,545.5%
AKLI's gross profit has soared by 147% QoQ
Akili's operating margin has soared by 86% YoY and by 47% from the previous quarter
The revenue has soared by 61% from the previous quarter
Akili's gross margin has soared by 53% from the previous quarter

Growth

What is Akili's growth rate over time

Valuation

What is Akili stock price valuation
P/E
N/A
P/B
0.33
P/S
11.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-24.04
AKLI's EPS is up by 31% from the previous quarter but it is down by 19% YoY
The price to book (P/B) is 64% lower than the last 4 quarters average of 0.9
Akili's equity has decreased by 47% YoY and by 15% QoQ
The price to sales (P/S) is 93% less than the last 4 quarters average of 152.0
The revenue has soared by 61% from the previous quarter

Efficiency

How efficient is Akili business performance
AKLI's ROS has plunged by 70% YoY but it is up by 44% from the previous quarter
The return on invested capital has dropped by 50% since the previous quarter
The return on equity has declined by 7% since the previous quarter
The company's return on assets fell by 6% QoQ

Dividends

What is AKLI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AKLI.

Financial health

How did Akili financials performed over time
The total assets has contracted by 44% YoY and by 14% from the previous quarter
Akili's quick ratio has decreased by 42% YoY and by 12% from the previous quarter
The debt is 74% less than the equity
Akili's equity has decreased by 47% YoY and by 15% QoQ
Akili's debt to equity has increased by 44% YoY and by 4% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.